Wockhardt recalls hypertension drug in US

Wockhardt recalls hypertension drug in US

FPJ BureauUpdated: Saturday, June 01, 2019, 12:50 PM IST
article-image

Hyderabad:  Wockhardt Ltd is recalling 109,744 bottles of anti-hypertensive drug belonging to multiple lots from the American market following failure of dissolution test, US regulator FDA said.  According to a notification by the USFDA, the recall is voluntarily and was initiated by the company from April 1 under ‘Class-II’ classification.             The recall of metoprolol is a generic version of AstraZeneca Plc’s branded drug Toprol.

RECENT STORIES

India’s Household Savings Rise To ₹54.6 Lakh Crore In FY24 But Share Of GDP Dips Slightly

India’s Household Savings Rise To ₹54.6 Lakh Crore In FY24 But Share Of GDP Dips Slightly

Akasa Air Secures IATA's Operational Safety Audit Safety Registration In Just 3 Years Of Operations

Akasa Air Secures IATA's Operational Safety Audit Safety Registration In Just 3 Years Of Operations

India’s Q2 GDP Soars 8.2% as Exports Stay Resilient Despite US Tariffs

India’s Q2 GDP Soars 8.2% as Exports Stay Resilient Despite US Tariffs

Atal Pension Yojana Enrolment Crosses 8.34 Crore: FM Nirmala Sitharaman Highlights Women’s Strong...

Atal Pension Yojana Enrolment Crosses 8.34 Crore: FM Nirmala Sitharaman Highlights Women’s Strong...

Industrial Output Slips To 14-Month Low, India’s Production & Demand Indicators Signal Early Signs...

Industrial Output Slips To 14-Month Low, India’s Production & Demand Indicators Signal Early Signs...